Clinical Trial

Cerebrospinal Fluid Kinetics of Urolithin A

Name: Cerebrospinal Fluid Kinetics of Urolithin A — clinical trial record (NCT07517913)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: neURO

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to determine the impact of Mitopure® consumption on urolithin A (UA) kinetics in cerebral spinal fluid (CSF).

Protocol Amendment History 1 change

minor Completion pushed: 2027-04-01 -> 2027-06-01 2026-07-30

Trial Details

NCT Number	NCT07517913
Lead Sponsor	Amazentis SA Collaborators: Mprex Healthcare Pvt. Ltd.
Conditions	Healthy Adult
Enrollment	40 participants
Start Date	2026-08-01
Primary Completion	2027-04-01 (estimated)
Study Completion	2027-06-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-29